JYOTHYLAB

Jyothy Labs Share Price

 

 

Invest in Jyothy Labs with 3.49X leverage

Invest with MTF
Jyothy Labs live price: ₹248.3. It opened at ₹243 vs previous close ₹246; intraday high/low: ₹251/₹240. The 50 & 200 DMA stand at ₹258.77/₹304.51.

Jyothy Labs Performance

  • Low
  • ₹240
  • High
  • ₹251
  • 52 Week Low
  • ₹237
  • 52 Week High
  • ₹400
  • Open Price₹243
  • Previous Close₹246
  • Volume636,343
  • 50 DMA₹258.77
  • 100 DMA₹276.32
  • 200 DMA₹304.51

Investment Returns

  • Over 1 Month + 1.85%
  • Over 3 Month -14.92%
  • Over 6 Month -26.18%
  • Over 1 Year -21.22%

Smart Investing Starts Here Start SIP with Jyothy Labs for Steady Growth!

Invest Now

Jyothy Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 26.6
  • PEG Ratio
  • -3.3
  • Market Cap Cr
  • 9,118
  • P/B Ratio
  • 6
  • Average True Range
  • 8.32
  • EPS
  • 9.97
  • Dividend Yield
  • 1.4
  • MACD Signal
  • -2.4
  • RSI
  • 46.95
  • MFI
  • 55.36

Jyothy Labs Financials

Jyothy Labs Technicals

EMA & SMA

Current Price
₹248.30
+ 2.5 (1.02%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹249.83
  • 50 Day
  • ₹258.77
  • 100 Day
  • ₹276.32
  • 200 Day
  • ₹304.51

Resistance and Support

246.5 Pivot Speed
  • R3 263.30
  • R2 257.10
  • R1 252.70
  • S1 242.10
  • S2 235.90
  • S3 231.50

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Jyothy Labs Ltd. is a leading Indian FMCG company offering household products like detergents, dishwash liquids, mosquito repellents, and personal care items. It operates across India with popular brands like Ujala, Exo, Maxo, and Pril, serving millions of households.

Jyothy Labs has an operating revenue of Rs. 2,893.84 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 17% is great, ROE of 18% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 29 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 151 indicates it belongs to a poor industry group of Soap & Clng Preparatns and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Jyothy Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-09 Quarterly Results
2025-11-12 Quarterly Results
2025-08-12 Quarterly Results
2025-05-12 Audited Results & Final Dividend
2025-01-31 Quarterly Results
Date Purpose Remarks
2025-08-28 FINAL Rs.3.50 per share(350%)Final Dividend
View Jyothy Labs Dividend History Arrow

Jyothy Labs F&O

Jyothy Labs Shareholding Pattern

62.89%
13.73%
0.99%
12.77%
0%
7.78%
1.84%

About Jyothy Labs

  • NSE Symbol
  • JYOTHYLAB
  • BSE Symbol
  • 532926
  • Chairperson & Managing Director
  • Ms. M R Jyothy
  • ISIN
  • INE668F01031

Similar Stocks to Jyothy Labs

Jyothy Labs FAQs

Jyothy Labs share price is ₹248 As on 05 March, 2026 | 01:25

The Market Cap of Jyothy Labs is ₹9117.9 Cr As on 05 March, 2026 | 01:25

The P/E ratio of Jyothy Labs is 26.6 As on 05 March, 2026 | 01:25

The PB ratio of Jyothy Labs is 6 As on 05 March, 2026 | 01:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23